Las Vegas, NV -- (SBWIRE) -- 10/05/2013 -- EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more .EquityObserver.com issues a special report on the following stocks: TherapeuticsMD Inc (NYSEMKT: TXMD), Life Technologies Corp. (NASDAQ:LIFE), Accuray Incorporated (NASDAQ:ARAY), Actavis Inc (NYSE:ACT)
TherapeuticsMD Inc (NYSEMKT: TXMD) managed to keep its gain at 8.92% on above-normal volume of 1.70M shares. The stock settled at $3.42 after floating in a range of $3.10 to $3.80. Its latest price has reached market capitalization of $495.77 million. Its 52-week range has been $1.25 to $3.80. TherapeuticsMD, Inc. promotes, distributes and sells certain products developed and sold by Spectrum Health Network, Inc. (Spectrum) relative to its digital media network.
For How Long TXMD will fight for Profitability? Read This Trend Analysis report
Life Technologies Corp. (NASDAQ:LIFE) traded up on a volume of 1.67 million, higher than its standard daily volume. Shares have gained 0.32% to $75.08. Over the last twelve months, the stock has gained 53.68% and faced a worst price of $45.67. Life Technologies Corporation (Life Technologies) is a global life sciences company. The Company's systems, consumables and services enable scientific researchers and commercial markets to accelerate scientific exploration, to discoveries and developments that improve the quality of life.
For How Long LIFE’s Gloss will Attract Investors? Find out via this report
Accuray Incorporated (NASDAQ:ARAY) settled 2.85% higher at $7.59 on above-normal volume of 1.64M shares during the last trading day. The stock has its 12-month high at $7.61 and 52-week low price was $3.76. It traded in a range of $7.36 to $7.61 during the last trading day. Accuray, Inc. manufactures image-guided radiosurgery devices. The Company is based in the United States and its core product, the CyberKnife Stereotactic Radiosurgery System.
Why Should Investors Buy ARAY After the Recent Fall? Just Go Here and Find Out
In the last trading session, Actavis Inc (NYSE:ACT) was up on high volume, trading at a volume of 1.64M versus its average daily volume of 1.51 million shares. At $146.90, the stock has attained market capitalization of 19.56 billion. Actavis, Inc., formerly Actavis PLC is a integrated global specialty pharmaceutical company engaged in the development, manufacturing, marketing, sale and distribution of generic, branded generic, brand, biosimilar and over-the-counter (OTC) pharmaceutical products.
Will ACT Continue To Move Higher? Find Out Here
About Equity Observer
Equity Observer delivers intra-day insights into the equities, tech and investment world. The website is a window into what’s going on in the business world and why.
EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more.
The disclaimer is to be read and fully understood before using our site, or joining our email list.
http://www.equityobserver.com/ has a no tolerance spam policy; we will not sell or re-distribute your email to any 3rd party. A If applicable, please also unsubscribe from the newsletter using the link at the bottom of the email if you no longer wish to receive our emails. We only send our newsletters to opt-in members.
PLEASE NOTE WELL: The http://www.equityobserver.com/" rel="nofollow" href="http://www.equityobserver.com/"> http://www.equityobserver.com/>
Employees and contributors are NOT registered as an Investment Adviser in any jurisdiction whatsoever.
Read Full Disclaimerat: http://www.equityobserver.com/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)